CALGARY, ALBERTA - January 13, 2025 (NEWMEDIAWIRE) - Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (OTC Pink:VYYRF) ("Voyageur" or the "Company") is pleased to announce that it has begun human testing on ...
Please provide your email address to receive an email when new articles are posted on . A new contrast sensitivity test demonstrated high reliability in identifying patients with glaucoma, according ...
Impaired vision and blindness are common. About 3.4 million people in the US are blind or visually impaired. Vision is usually measured by visual acuity charts, and normal vision is expressed as 20/20 ...
In part six of a series from the OSN Technology and Equipment Workshop featured at Hawaiian Eye 2010, Jack T. Holladay, MD, MSEE, FACS, presented a new contrast sensitivity testing device that offers ...